ExeVir Bio Competitors and Similar CompaniesClear all
ExeVir Bio's competitors and similar companies include StrideBio.
 ExeVir Bio ExeVir Bio is a company that harnesses a llama-derived antibody technology platform to generate antiviral therapies providing broad protection against coronaviruses. |  StrideBio StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral vector technologies and therapeutics for rare diseases. | |
Founding Date | Founding Date 2020 | Founding Date 2015 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations Gent, BE HQ | Locations US HQ |
Employees | Employees 1611% decrease | Employees 5 |
Funding | ||
Latest funding round | Latest funding round $ 23m (about 5 years ago) | Latest funding round $ 81.5m (about 5 years ago) |
Total funding raised | Total funding raised $ 50m | Total funding raised $ 97.2m |
For sources of this data, please see the company profile
View Company Profiles
StrideBio
HQ
US
Employees
5
StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral vector technologies and therapeutics for rare diseases.
View company